Clinical trials: Food Allergy Peanut

Peanut Allergy

Phase I Trial to Evaluate VLP Peanut in Healthy and Peanut Allergic Subjects

• Active, not recruiting
• Age: 18 to 50 years
• Phase 1

This phase I clinical trial is designed to evaluate the safety and tolerability of VLP Peanut in healthy subjects and in subjects with peanut allergy (PA).

Trial name

PROTECT (NCT05476497)

Testing

VLP Peanut

Where

10 sites in United States

Volunteers

46 people, healthy volunteers welcome

Sponsor

Allergy Therapeutics